Sort
40,608 grants matching “prostate cancer”
Detection of in vivo enzyme activities with CEST MRI
$526,052Mark David Pagel · University Of Arizona · R01 · FY2014 · CA
IDENTIFYING AND TARGETING PROSTATE CANCER THERAPY RESISTANCE MECHANISMS DRIVEN BY THE TUMOR MICROENVIRONMENT
$526,042Fred Hutchinson Cancer Center · · FY2025 · Defense Health Agency
DEFINING THE ENDOCRINOLOGY OF NEUROENDOCRINE PROSTATE CANCER TO IDENTIFY MICROENVIRONMENT DRIVERS OF TREATMENT RESISTANCE
$525,999Fred Hutchinson Cancer Center · · FY2025 · Defense Health Agency
Utilizing genetic and functional strategies to identify causal genes and alleles
$525,949Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2014 · GM
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer
$525,898Jin Xie · University Of Georgia · R01 · FY2023 · CA
DEFINING AND EXPLOITING ESSENTIAL COMPONENTS OF THE ANDROGEN RECEPTOR PROGRAM OPERATIVE IN CASTRATION-RESISTANT PROSTATE CANCERS
$525,847Fred Hutchinson Cancer Center · · FY2025 · Defense Health Agency
GRANZYME B PET AS A NOVEL MEANS TO ASSESS T-CELL ACTIVATION IN RESPONSE TO 177LU-PSMA-617 PRIMING IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
$525,753Regents Of The University Of California, San Francisco, The · · FY2022 · Defense Health Agency
Pathogenesis of human prostate carcinomas
$525,720University Of Southern California · R01 · FY2004 · CA
The IGF Signaling Pathway and Breast Cancer Risk
$525,564Susan L. Neuhausen · University Of California-Irvine · R01 · FY2008 · CA
DEVELOPING NOVEL THERAPEUTIC STRATEGIES FOR CASTRATION-RESISTANT PROSTATE CANCER
$525,539Purdue University · · FY2014 · Department of the Army
Core B: Administrative and Data Management Core
$525,500Michael M. Shen · Columbia University Health Sciences · P01 · FY2022 · CA
A dyadic exercise approach to prevent declines in physical and mental health in couples during radiation treatment for cancer: a hybrid type I efficacy-implementation trial
$525,495Kerri M Winters-Stone · Oregon Health & Science University · R01 · FY2024 · CA
OSTEOPOROTIC FRACTURES IN MEN
$525,455University Of Pittsburgh At Pittsburgh · U01 · FY2001 · AR
Pulsed Focused Ultrasound (pFUS) exposures and devices for tissue permeabilization without contrast agents
$525,159Tatiana Khokhlova · University Of Washington · R01 · FY2019 · EB
Flexible NLP toolkit for automatic curation of outcomes for breast cancer patients
$525,159Imon Banerjee · Mayo Clinic Arizona · U01 · FY2022 · CA
Validation of prognostic and pathway signatures in lethal prostate cancer
$525,083Phillip G Febbo · University Of California, San Francisco · U01 · FY2012 · CA
Metastasis of PTEN Mutant Prostate Cancer
$525,040Lloyd C Trotman · Cold Spring Harbor Laboratory · R01 · FY2024 · CA
Validation of blood-based biomarkers for risk assessment of lung cancer among individuals with no smoking history in the PLCO Cohort
$525,013Edwin Justin Ostrin · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · CA
Prostate-cancer Imaging by Combined Ultrasound and Magnetic-resonance Parameters
$525,013Ernest Joseph Feleppa · Riverside Research Institute · R01 · FY2013 · CA
MS/AL Radiation Oncology Research Partnership
$525,000James E. Clarkson · Singing River Health System · U54 · FY2009 · CA
FUNCTION-BASED THERAPEUTIC STRATEGIES TO HUMAN PROSTATE CANCER
$525,000The Morehouse School Of Medicine, Inc. · · FY2008 · Department of the Army
ERG AND PROSTATE CANCER
$525,000The Morehouse School Of Medicine, Inc. · · FY2009 · Department of the Army
Role of Neurotrophins in the Development of the Mammalian Nervous System
$524,951Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
"Molecular Signatures of Lethal and Indolent Prostate Cancer"
$524,925Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · CA
Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI
$524,826Aytekin Oto · University Of Chicago · R01 · FY2023 · CA